# Gout Journal Club

Page: https://stenobird.com/podcast/rheumnow-podcast-587987/gout-journal-club
Text version: https://stenobird.com/podcast/rheumnow-podcast-587987/gout-journal-club.md
Podcast: [Rheumnow Podcast](https://stenobird.com/podcast/rheumnow-podcast-587987)
Published: 2026-07-08T12:56:53+00:00
Episode link: https://rheumnow.podbean.com/e/gout-journal-club/
Audio file: https://mcdn.podbean.com/mf/web/kbbfc2dgh9tyyznt/Gout_Journal_Club5zvu3.mp3
Processing state: not_requested
JSON: https://stenobird.com/v1/public/podcasts/rheumnow-podcast-587987/episodes/gout-journal-club
Duration seconds: 3446

## Resource

Gout Journal Club will examine two influential publications: 1. "Treat-to-Target Urate-Lowering Treatment and Cardiovascular Outcomes in Patients with Gout" (Cipolletta et al., JAMA Internal Medicine, 2026) and 2. "Target Serum Urate Achievement and Chronic Kidney Disease Progression in Patients With Gout and Kidney Disease"(Wang et al., JAMA Internal Medicine, 2025). Together, these studies provide new evidence supporting treat-to-target urate-lowering strategies and their potential impact on cardiovascular and renal outcomes. Panelists: Abhishek Abhishek, MD, PhD, MBBS, FRCP Zeqin Wen, MD Jie Wei, PhD Jack Cush, MD (moderator) Beyond reviewing the evidence, our expert panel will tackle the practical questions rheumatologists face every day.

## Actions

- request_transcript: `POST https://stenobird.com/v1/public/podcasts/rheumnow-podcast-587987/episodes/gout-journal-club/transcription-requests` — Idempotently request low-priority transcript generation for this episode.
- read_markdown: `GET https://stenobird.com/podcast/rheumnow-podcast-587987/gout-journal-club.md` — Read the agent-friendly Markdown representation of this episode resource.

A page view does not enqueue transcription. Agents should invoke `request_transcript` explicitly when they need this episode processed.

## Transcript

Full transcripts are not published on public pages unless there is a clear rights basis.